» Articles » PMID: 32626660

RNA-Seq Profiling of Serum Exosomal Circular RNAs Reveals Circ-PNN As a Potential Biomarker for Human Colorectal Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Jul 7
PMID 32626660
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are emerging as cardinal areas of focus in the non-coding RNA field. Growing evidences have revealed exosomal circRNAs as potential biomarkers for detection of various cancers. However, the clinical importance of most serum exosomal circRNAs in colorectal cancer (CRC) have rarely been investigated. In this study, we examined the possible clinical application of serum exosomal circRNAs in the diagnosis of CRC. Firstly, we conducted RNA sequencing (RNA-seq) analysis using fifty CRC and fifty healthy control serum samples to identify CRC-related circRNAs. The sequencing data showed 122 differentially expressed circRNAs including 100 up-regulated and 22 down-regulated circRNA transcripts in CRC patients. Then, eight most dysregulated circRNAs were selected for validation by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay. Validation analysis revealed that the serum exosomal circ-PNN (hsa_circ_0101802) levels were significantly up-regulated in CRC cases compared with those in the healthy control groups. Receiver operating characteristic curve (ROC) analysis suggested that circ-PNN had significant value in CRC diagnosis with areas under the ROC curve (AUC) of 0.855 and 0.826 in the training and validation sets, respectively. We also found that the AUC of serum exosomal circ-PNN for early-stage CRC was 0.854. Finally, a network map based on circ-PNN was constructed to determine its potential miRNA-mRNAs binding. We also demonstrated that the expression of hsa-miR-6833-3P, hsa-let-7i-3p and hsa-miR-1301-3P were negatively correlated with circ-PNN in CRC patients. Collectively, our findings indicated that serum exosomal circ-PNN might be a potential non-invasive biomarker for the detection of CRC and may play a crucial role in the pathogenesis of CRC.

Citing Articles

Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy.

Li X, Liu H, Xing P, Li T, Fang Y, Chen S J Pharm Anal. 2025; 15(2):101067.

PMID: 39957900 PMC: 11830318. DOI: 10.1016/j.jpha.2024.101067.


Investigating the biomarker value of circRNAs in the diagnosis of colorectal cancer: a systematic review.

Latifi-Pakdehi T, Khezrian A, Doosti-Irani A, Afshar S, Mahdavinezhad A Discov Oncol. 2024; 15(1):734.

PMID: 39616555 PMC: 11609141. DOI: 10.1007/s12672-024-01602-z.


Biological functions and molecular mechanisms of exosome-derived circular RNAs and their clinical implications in digestive malignancies: the vintage in the bottle.

Lou Y, Yan J, Liu Q, Miao M, Shao Y Ann Med. 2024; 56(1):2420861.

PMID: 39484707 PMC: 11536637. DOI: 10.1080/07853890.2024.2420861.


Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.

Shi X, Zhao X, Xue J, Jia E BMC Cancer. 2024; 24(1):623.

PMID: 38778252 PMC: 11110411. DOI: 10.1186/s12885-024-12312-8.


The multifaceted role of extracellular vesicles (EVs) in colorectal cancer: metastasis, immune suppression, therapy resistance, and autophagy crosstalk.

Rahmati S, Moeinafshar A, Rezaei N J Transl Med. 2024; 22(1):452.

PMID: 38741166 PMC: 11092134. DOI: 10.1186/s12967-024-05267-8.


References
1.
Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C . Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112(2):594-642. DOI: 10.1053/gast.1997.v112.agast970594. View

2.
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B . Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016; 7:11215. PMC: 4823868. DOI: 10.1038/ncomms11215. View

3.
Zhu C, Sha X, Wang Y, Li J, Zhang M, Guo Z . Circular RNA hsa_circ_0007142 Is Upregulated and Targets miR-103a-2-5p in Colorectal Cancer. J Oncol. 2019; 2019:9836819. PMC: 6617873. DOI: 10.1155/2019/9836819. View

4.
Wang B, Wu H, Chai C, Lewis J, Pichiorri F, Eisenstat D . MicroRNA-1301 suppresses tumor cell migration and invasion by targeting the p53/UBE4B pathway in multiple human cancer cells. Cancer Lett. 2017; 401:20-32. DOI: 10.1016/j.canlet.2017.04.038. View

5.
Dong Y, He D, Peng Z, Peng W, Shi W, Wang J . Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017; 10(1):2. PMC: 5210264. DOI: 10.1186/s13045-016-0370-2. View